Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / United Kingdom

Teva, Taro Target UK

November 2006 | Company Finance Alert

Israeli drugmakers Teva and Taro are to expand activities in the UK. Teva - the world's largest generics firm - has signed a deal with Schering-Plough to co-promote products for Inflammatory Bowel Disease (IBD) for the UK market. Meanwhile, Taro has secured two approvals for generic formulations of branded products made by two UK

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
GSK Looks To Outsourcing For Emerging Market Growth

Industry / United Kingdom The UK's GlaxoSmithKline (GSK) has entered into an agreement with South Africa's Aspen Pharmacare, which it hopes will accelerate its sales in emerging markets. BMI believes that GSK's main motivation...
July 2008
Teva Showcases Novel Drug Pipeline

Companies / Israel In an attempt to draw attention away from its successful but stable generic business, Israeli firm Teva Pharmaceutical Industries has showcased its pipeline of branded pharmaceuticals. Teva is planning...
September 2006
Teva Signals Pause In Acquisitions Quest

Companies / Israel Teva has also received final approval for Azilect (rasagiline), its proprietary drug for Parkinson's disease, from the US FDA. European and Israeli regulators approved the drug in 2005, and large-scale...
May 2006
Politics, Hi-Tech Products Strain Israel's Drug Basket

Companies / Israel Israel's Health Basket - which offers live-saving drugs to many citizens not covered by the country's sick funds - remains controversial. The scheme's ongoing problems are attributed to a funding crisis,...
April 2006
Israel's Taro, India's JB Sign Development Deal

Companies / Israel Following generics maker Taro's alliance with India's Alkem, new reports claim the Israeli firm has agreed a product development alliance with another Indian manufacturer, JB Chemicals & Pharmaceuticals....
January 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS